Posts - CLL Support | HealthUnlocked
All posts for September 2014
Explainer: how does the immune system work?
Our immune system - we take it for granted until it begins to fail us. Unfortun...
New HU Features for the News feed and Community Pages
Following feedback, HU have changed the display of the Community home page ( ht...
Want to take advantage of all our features? Just log in!
or
Positives in negative results: when finding ‘nothing’ means something
"It’s important to publish all results – both positive and negative – if researc...
Clearing up confusion between correlation and causation
Those of us interested in attempts to identify the cause of cancers and the long...
FDA Grants Special Protocol Assessment to Phase III Ublituximab/Ibrutinib Study
"TG Therapeutics has reached an agreement with the FDA regarding a Special Proto...
Why research beats anecdote in our search for knowledge
Tim Dean, Philosopher at the University of New South Wales, Australia argues the...
Dr Sharman's Idelalisib (Zydelig) Update based on European experience
There's been some concern on the FDA requirement for a black box warning on the ...
Video, Gwyneth Stafford discusses managing CLL symptoms
Gwyneth Stafford CLL & Lymphoma Nurse Specialist at Cambridge University Hospita...
European Commission Grants Marketing Authorization for Gilead’s Zydelig® (Idelalisib) for the Treatment of Chronic Lymphocytic Leukemia
Gilead press release
European Commission Grants Marketing Authorization for ...
New HU Site Features released - Notifications and Top Monthly post
HU have just informed me of two new features just released:
1) In platform noti...
ONCOLOGY Review Articles: September 2014 Issue. Plenty of interesting reading
Free membership of The Cancer Network will provide you with a monthly Oncology R...
Nutraceuticals are often big on promise but fail to deliver
Nial Wheate, Senior Lecturer in Pharmaceutical Chemistry at University of Sydne...